February 2018 FDA Recall Drug by Akorn, Inc.
D-0577-2018 - Failed Stability Specification

This Class III drug recall was voluntarily initiated by Akorn, Inc. on February 21, 2018 for the product Drug. The FDA reported the reason for recall as failed stability specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0577-2018

Reason for Recall
Failed Stability Specification: OOS low viscosity results discovered during retain testing.
Initiated
02-21-2018
Reported
03-14-2018
Quantity
31,812 bottles

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
79278
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Akorn, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide in the USA
Termination Date About Termination Date
Date that FDA officially terminated the recall.
08-31-2020
Product Description About Product Description
Full technical description of the product.
Atropine Sulfate Ophthalmic 1% Solution, USP, 5mL per bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-215-05

Batch or Lot Expiration Information

Lot# Lot: 011037A